Skip to main content

Cambian Group Share Forecast, Price & News

GBX 192.40
-0.60 (-0.31 %)
(As of 10/18/2018)
Today's Range
50-Day Range
52-Week Range
Volume54,471 shs
Average Volume111,905 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive CMBN News and Ratings via Email

Sign-up to receive the latest news and ratings for Cambian Group and its competitors with MarketBeat's FREE daily newsletter.

Cambian Group logo

About Cambian Group

Cambian Group plc, together with its subsidiaries, provides specialist educational and behavioral health services for children in the United Kingdom. It offers services in the areas of autism and learning difficulties, residential care and education, therapeutic fostering care and emotional support, and deaf. The company delivers its services through a network of 222 specialist children's facilities in England and Wales. In addition, it is involved in property and trading businesses. The company was formerly known as Project Zelda plc and changed its name to Cambian Group plc in March 2014. Cambian Group plc was founded in 2003 and is based in London, the United Kingdom.


See More Headlines

Industry, Sector and Symbol

Industry Medical Care
Year FoundedN/A

Sales & Book Value

Annual SalesN/A





Next Earnings DateN/A
OptionableNot Optionable


Overall MarketRank

0.64 out of 5 stars

Analyst Opinion: 0.0Community Rank: 3.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Cambian Group (LON:CMBN) Frequently Asked Questions

What stocks does MarketBeat like better than Cambian Group?

Wall Street analysts have given Cambian Group a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cambian Group wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Cambian Group's key executives?

Cambian Group's management team includes the following people:
  • Mr. Saleem Asaria, CEO & Exec. Director (Age 53)
  • Mr. Anoop Kang, CFO & Exec. Director
  • Ms. Anne Marie Carrie, COO & Exec. Director (Age 62)
  • Ms. Catherine Jane Apthorpe, Head of Legal & Company Sec. (Age 39)
  • Mr. Mike McQuaid, Managing Director of Adult Services

Who are some of Cambian Group's key competitors?

What other stocks do shareholders of Cambian Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cambian Group investors own include CareTech (CTH), Adtalem Global Education (ATGE), EnQuest (ENQ), Medicx Fund (MXF), Target Healthcare REIT (THRL), (UPLMQ) (UPLMQ), Welltower (WELL), Bodycote (BOY), Diageo (DEO) and Nufarm (NUFMF).

What is Cambian Group's stock symbol?

Cambian Group trades on the London Stock Exchange (LON) under the ticker symbol "CMBN."

How do I buy shares of Cambian Group?

Shares of CMBN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Cambian Group's stock price today?

One share of CMBN stock can currently be purchased for approximately GBX 192.40.

What is Cambian Group's official website?

The official website for Cambian Group is

Where are Cambian Group's headquarters?

Cambian Group is headquartered at 4th Floor, Waterfront Building Chancellors Road, Hammersmith Embankment, LONDON, W6 9RU, United Kingdom.

How can I contact Cambian Group?

Cambian Group's mailing address is 4th Floor, Waterfront Building Chancellors Road, Hammersmith Embankment, LONDON, W6 9RU, United Kingdom. The health services provider can be reached via phone at +44-20-87356150.

This page was last updated on 5/16/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.